Skip to main content
Year archive

Alligator Bioscience — 2017 filings

All 41 regulatory filings released by Alligator Bioscience (ATORX) in 2017, sourced directly from the official regulator.

41 Filings
2017 Period
2017 filings (41)
Filing Released Lang
Alligator Bioscience expands management team
Board/Management Information
2017-12-04 English
Alligator Bioscience utökar ledningsgruppen
Board/Management Information
2017-12-04 Swedish
Nomination Committee appointed in respect of AGM 2018 in Alligator Bioscience AB
AGM Information
2017-11-13 English
Valberedning utsedd inför årsstämma 2018 i Alligator Bioscience AB
AGM Information
2017-11-13 Swedish
Resultaten från Alligator Biosciences kliniska fas I-studie stödjer fortsatt klinisk utveckling av ADC-1013
Regulatory Filings
2017-11-07 Swedish
Results from Alligator Bioscience’s clinical phase I study support further clinical development of ADC-1013
Regulatory Filings
2017-11-07 English
Interim / Quarterly Report 2017
Interim / Quarterly Report 9M 2017
2017-10-25 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report 9M 2017
2017-10-25 English
Alligator Bioscience Aptevo Therapeutics: Tumor antigen 5T4 associated with many forms of solid tumors identified as the second target for ALG.APV-527
Regulatory Filings
2017-10-24 English
Alligator Bioscience och Aptevo Therapeutics: Tumörantigenet 5T4, uttryckt på många olika solida tumörer, är den andra målmolekylen för ALG.APV-527
Regulatory Filings
2017-10-24 Swedish
Major Shareholding Notification 2017
Major Shareholding Notification
2017-10-16 English
Alligator Bioscience to present ADC-1013 intratumoral clinical phase I study results at SITC in November 2017
Regulatory Filings
2017-09-21 English
Alligator Bioscience presenterar resultat från en klinisk fas I-studie (intratumoral) med ADC-1013 på SITC i november 2017
Regulatory Filings
2017-09-21 Swedish
Alligator Bioscience signs immunotherapy research collaboration agreement for 4-1BB
Regulatory Filings
2017-09-13 English
Alligator Bioscience tecknar forskningsavtal gällande 4-1BB för immunterapi
Regulatory Filings
2017-09-13 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report H1 2017
2017-08-23 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report H1 2017
2017-08-23 English
Aptevo Therapeutics och Alligator Bioscience inleder CTA-förberedande aktiviteter för den bispecifika immunonkologiska antikroppen ALG.APV-527
Regulatory Filings
2017-08-17 Swedish
Aptevo Therapeutics and Alligator Bioscience commence IND-enabling development activities for new bispecific immunotherapy candidate ALG.APV-527
Regulatory Filings
2017-08-17 English
Aptevo Therapeutics and Alligator Bioscience announce plans to co-develop novel bispecific antibody for tumor-directed immunotherapy
Regulatory Filings
2017-07-21 English
Aptevo Therapeutics och Alligator Bioscience inleder samutveckling av bispecifik antikropp för tumörriktad immunterapi
Regulatory Filings
2017-07-21 Swedish
Alligator inleder preklinisk utveckling med den immunonkologiska 4-1BB antikroppen ATOR-1017
Regulatory Filings
2017-06-12 Swedish
Alligator advances 4-1BB immuno-oncology antibody ATOR-1017 topre-clinical development
Regulatory Filings
2017-06-12 English
Alligator Bioscience presents promising immuno-oncology data at US conference; - Strong new preclinical findings for ADC-1013 and ATOR-1015
Regulatory Filings
2017-05-04 English
Alligator Bioscience presenterar lovande immunonkologidata på USA-konferens; - Stark ny preklinisk dokumentation för ADC-1013 och ATOR-1015
Investor Presentation
2017-05-04 Swedish
Kommuniké från årsstämma den 2 maj 2017 i Alligator Bioscience AB (Publ)
AGM Information
2017-05-02 Swedish
Bulletin from the annual shareholders’ meeting in Alligator Bioscience AB (publ) on May 2, 2017
AGM Information
2017-05-02 English
Interim / Quarterly Report 2017
Interim / Quarterly Report Q1 2017
2017-05-02 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Q1 2017
2017-05-02 English
Change in number of shares and votes in Alligator Bioscience AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2017-03-31 English
Ändring av antalet aktier och röster i Alligator Bioscience AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2017-03-31 Swedish
Alligator announces completion of first phase I study with CD40 agonistic immuno-oncology antibody ADC-1013
Regulatory Filings
2017-03-23 English
Alligator meddelar fullbordande av den första kliniska fas I-studien med den CD40-agonistiska immunonkologiska antikroppen ADC-1013
Regulatory Filings
2017-03-23 Swedish
Annual Report 2016
Annual Report FY 2016
2017-03-22 Swedish
Report Publication Announcement 2017
Report Publication Announcement
2017-03-22 English
Notice of annual shareholders’ meeting in Alligator Bioscience AB (publ)
AGM Information
2017-03-22 English
Kallelse till årsstämma i Alligator Bioscience AB (publ)
AGM Information
2017-03-22 Swedish
Earnings Release 2016
Earnings Release FY 2016
2017-02-17 Swedish
Audit Report / Information 2016
Audit Report / Information FY 2016
2017-02-17 English
Change in number of shares and votes in Alligator Bioscience AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2017-01-31 English
Ändring av antalet aktier och röster i Alligator Bioscience AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2017-01-31 Swedish